期刊文献+

CXCL12基因多态性与肿瘤易感性关联的Meta分析 被引量:1

Meta-analysis the association of CXCL12 polymorphism and neoplasms susceptivity
原文传递
导出
摘要 目的运用Meta分析方法综合评价CXCL12 rs1801157基因多态性与肿瘤发病的关系。方法通过计算机检索和手工检索,收集有关CXCL12 rs1801157基因多态性与肿瘤易感性关系的文献,筛选出符合条件的文献,运用Meta分析方法对各项研究进行异质性检验后计算合并OR值及其95%可信区间,并进行敏感性分析及发表偏倚的评估。结果 15篇符合条件的文献纳入本研究,累积病例组3 225例,对照组4 001例。Meta分析合并结果显示突变等位基因A携带者相比野生等位基因G携带者肿瘤发病风险显著提高,合并值OR=1.27 95%CI=1.12~1.43,差异有统计学意义(P<0.01);基因型AA∶GG,GA∶GG和(AA+GA)∶GG合并OR值及其95%可信区间分别是1.30,95%CI=1.05~1.61、1.45,95%CI=1.22~1.72和1.43,95%CI=1.21~1.68,差异均有统计学意义。按肿瘤类型进行分层,A等位基因携带者相比G等位基因携带者显著提高乳腺癌发病(OR=1.32,95%CI=1.15~1.51,P<0.01);AA∶GG,GA∶GG和(AA+GA)∶GG合并OR值及其95%可信区间分别是1.64,95%CI=1.16~2.33、1.42,95%CI=1.18~1.70和1.44,95%CI=1.21~1.72。结论 CXCL12 rs1801157基因多态性与肿瘤易感性有关,突变等位基因A与肿瘤易感性升高有关,基因型AA或基因型GA携带者相对基因型GG携带者肿瘤发病风险提高。突变等位基因A增加乳腺癌易感性。 Objective To analysis the relationship between polymorphism gene of CXCL12 rs1801157 and tumor susceptibility by Meta - analysis. Method Collecting relevant literatures about the association between polymorphism gene of CXCL12rs1801157 and tumor susceptibility under the same criteria by computer retrieval and manual retrieval. Carrying out heterogeneity inspection by Meta - analysis, calculation the OR value and 95% confidence interval, sensitivity and publication bias were evaluated. Results 15 literatures with 3 225 eases and 4 001 controls were included. Onset risk of mutation allele A carrier was obvious higher than wild al- lele gene G carrier, OR = 1.27, 95% CI were 1.12 to 1.43, the difference had statistical significance (P 〈 0. 01) . The OR value and 95%CI of genotype of AA: GG, GA: GG, OR = 1.30, 95% CI = 1.22 - 1.72, (AA + GA) : GG, OR = 1.43, 95% CI = 1.21 - 1.68. Stratified by tumor types, we found that the breast cancer incidence rate of allele A cartier was higher than allele A cartier G, OR = 1.64, 95% CI = 1.16 - 2. 33. GA:GG, 0R=1.42, 95%CI=1.18 ~I.70. AA+GA:GG, OR=1.44, 95%CI=1.21-1.72. Condusiom CXCL12rs1801157 polymorphism gene was association with tumor susceptibility. Carriers of genotype AA or GA may association with the high risk of tumor compared with GG genetype. Allele A was a risk factor of breast cancer.
作者 石庆芳
出处 《医学动物防制》 2012年第7期746-750,共5页 Journal of Medical Pest Control
关键词 CXCL12 肿瘤 多态性 META分析 CXCL12 Tumor Polymorphism Meta - Analysis
  • 相关文献

参考文献19

  • 1Winkler C,Modi W,Smith MW,et al.Genetic restriction of AIDSpathogenesis by an SDF-1 chemokine gene variant ALIVE Study,He-mophilia Growth and Development Study(HGDS),Multicenter AIDSCohort Study(MACS),Multicenter Hemophilia Cohort Study(MH-CS),San Francisco City Cohort(SFCC)[J].Science,1998,279(5 349):389-393.
  • 2Zafiropoulos A,Crikas N,Passam AM,et al.Significant involvementof CCR2-64I and CXCL12-3a in the development of sporadic breastcancer[J].J Med Genet,2004,41(5):59.
  • 3Razmkhah M,Talei AR,Doroudchi M,et al.Stromal cell-derivedfactor-1(SDF-1)alleles and susceptibility to breast carcinoma[J].Cancer Lett,2005,225(2):261-266.
  • 4Razmkhah M,Doroudchi M,Ghayumi SM,et al.Stromal cell-de-rived factor-1(SDF-1)gene and susceptibility of Iranian patientswith lung cancer[J].Lung Cancer,2005,49(3):311-315.
  • 5Dimberg J,Hugander A,Lǒfgren S,et al.Polymorphism and circu-lating levels of the chemokine CXCL12 in colorectal cancer patients[J].Int J Mol Med,2007,19(1):11-15.
  • 6Hirata H,Hinoda Y,Kikuno N,et al.CXCL12 G801A polymor-phism is a risk factor for sporadic prostate cancer susceptibility[J].Clin Cancer Res,2007,13(17):5 056-5 062.
  • 7de Oliveira CE,Cavassin GG,Perim Ade L,et al.Stromal cell-de-rived factor-1 chemokine gene variant in blood donors and chronic my-elogenous leukemia patients[J].J Clin Lab Anal,2007,21(1):49-54.
  • 8Hidalgo-Pascual M,Galan JJ,Chaves-Conde M,et al.Analysis ofCXCL12 3'UTR G>A polymorphism in colorectal cancer[J].OncolRep,2007,18(6):1 583-1 587.
  • 9Khademi B,Razmkhah M,Erfani N,et al.SDF-1 and CCR5 genespolymorphism in patients with head and neck cancer[J].Pathol On-col Res,2008,14(1):45-50.
  • 10Lin GT,Tseng HF,Yang CH,et al.Combinational polymorphismsof seven CXCL12-related genes are protective against breast cancer inTaiwan[J].OMICS,2009,13(2):165-172.

二级参考文献10

  • 1[1]Murdoch C.CXCR4:chemokine receptor extraordinaire[J].Immunol Rev,2000,177(355):175-184.
  • 2[2]Brigati C,Noonan DM,Albini A,et al.Tumors and inflammatory infiltrates:friends or foes?[J].Clin Exp Metastasis,2002,19(3):247-258.
  • 3[3]Schimanski CC,Schwald S,Simiantonaki N,et al.Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer[J].Clin Cancer Res,2005,11(5):1743-1750.
  • 4[4]Peled A,Kollet O,Ponomaryov T,et al.The chemokine SDF-1 activates the integrins LFA-1,VLA-4,and VLA-5 on immature human CD+34 cells:role in transendothelial/stromal migration and engraftment of NOD/SCID mice[J].Blood,2000,95 (11):3289-3296.
  • 5[5]Muller A,Homey B,Soto H,et al.Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,410(6824):50-56.
  • 6[6]Kijowski J,Baj-Krzyworzeka M,Majka M,et al.The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells[J].Stem Cells,2001,19 (5):453-466.
  • 7[7]Tachibana K,Hirota S,Lizasa H,et al.The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract[J].Nature,1998,393(6685):591-594.
  • 8[8]Salvucci O,Lei Y,Villalba S,et al.Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1[J].Blood,2002,99(8):2703-2711.
  • 9[9]Bachelder RE,Wendt MA,Mercurio AM.Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4[J].Cancer Res,2002,62(24):7203-7206.
  • 10[10]Ceradini DJ,Kulkarni AR,Callaghan MJ,et al.Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1[J].Nat Med,2004,10(8):858-864.

共引文献3

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部